Yan Ji Selected Research

Ischemic Stroke

8/2022	Stroke incidence and cognitive outcomes of intracranial atherosclerotic stenosis: study protocol for a multicenter, prospective, observational cohort study.
1/2015	Prognostic Significance of Homocysteine Levels in Acute Ischemic Stroke: A Prospective Cohort Study.
1/2015	Homocysteine Level Is Associated with White Matter Hyperintensity Locations in Patients with Acute Ischemic Stroke.
10/2013	Functional recovery after transplantation of induced pluripotent stem cells in a rat hemorrhagic stroke model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yan Ji Research Topics

Disease

29	Neoplasms (Cancer) 03/2024 - 12/2003
19	Breast Neoplasms (Breast Cancer) 03/2024 - 10/2004
17	Inflammation (Inflammations) 09/2023 - 01/2008
8	Carcinogenesis 10/2018 - 10/2004
7	Infections 03/2024 - 07/2008
5	Body Weight (Weight, Body) 01/2024 - 01/2007
4	Neutropenia 01/2024 - 09/2020
4	Neoplasm Metastasis (Metastasis) 01/2023 - 11/2021
4	Ischemic Stroke 08/2022 - 10/2013
4	Cataract (Cataracts) 06/2020 - 01/2017
4	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 03/2017
3	Myopia 01/2022 - 12/2014
3	Uveitis 01/2022 - 12/2018
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2020 - 10/2015
3	Obesity 01/2020 - 07/2012
3	Hypoxia (Hypoxemia) 01/2017 - 11/2002
3	Carcinoma (Carcinomatosis) 12/2016 - 10/2004
3	Stroke (Strokes) 01/2015 - 10/2013
3	Leukemia 06/2006 - 05/2002
2	Virus Diseases (Viral Diseases) 04/2024 - 07/2008
2	Cognitive Dysfunction 02/2024 - 08/2022
2	Autoimmune Diseases (Autoimmune Disease) 11/2023 - 08/2019
2	Chronic Urticaria 09/2023 - 01/2023
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2023 - 10/2013
2	Cerebral Small Vessel Diseases 01/2023 - 01/2023
2	Vascular Remodeling 06/2022 - 11/2016
2	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 10/2006
2	Colitis 01/2021 - 01/2019
2	Lung Neoplasms (Lung Cancer) 07/2020 - 11/2019
2	Vesicular Stomatitis 07/2020 - 10/2015
2	Corneal Edema 06/2020 - 12/2019
2	Hypertension (High Blood Pressure) 01/2020 - 12/2018
2	Atherosclerosis 01/2020 - 01/2015
2	Pneumonia (Pneumonitis) 01/2019 - 02/2009
2	Stomach Neoplasms (Stomach Cancer) 10/2018 - 12/2016
2	Hyperplasia 11/2016 - 08/2011
2	Osteoporosis 01/2016 - 11/2014
2	Cerebral Hemorrhage 08/2015 - 08/2013
2	Hemorrhagic Stroke 10/2013 - 10/2013
2	Myeloid Leukemia (Leukemia, Myelocytic) 06/2006 - 10/2005

Drug/Important Bio-Agent (IBA)

12	ribociclibIBA 03/2024 - 01/2020
11	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2003
9	CytokinesIBA 04/2024 - 01/2008
9	Hormones (Hormone)IBA 03/2024 - 09/2020
6	Biomarkers (Surrogate Marker)IBA 01/2023 - 10/2013
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2023 - 09/2010
5	Messenger RNA (mRNA)IBA 01/2022 - 02/2009
4	Epidermal Growth Factor (EGF)IBA 01/2024 - 10/2020
4	Glucose (Dextrose)FDA LinkGeneric 09/2023 - 01/2019
4	HomocysteineIBA 01/2020 - 10/2013
4	Vitamin D FDA LinkGeneric 10/2006 - 01/2004
3	Aromatase InhibitorsIBA 03/2024 - 01/2021
3	CholesterolIBA 01/2023 - 07/2009
3	Long Noncoding RNAIBA 12/2022 - 12/2016
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 02/2009
3	Plasminogen Activator Inhibitor 1IBA 01/2020 - 08/2011
3	Interleukin-6 (Interleukin 6)IBA 01/2020 - 02/2009
3	RNA (Ribonucleic Acid)IBA 01/2018 - 01/2003
3	LipopolysaccharidesIBA 12/2016 - 07/2009
3	IsothiocyanatesIBA 10/2009 - 12/2004
3	phenethyl isothiocyanate (PEITC)IBA 09/2005 - 12/2003
2	Antiviral Agents (Antivirals)IBA 03/2024 - 07/2020
2	Fulvestrant (Faslodex)FDA Link 01/2024 - 01/2021
2	Advanced Glycation End ProductsIBA 09/2023 - 03/2023
2	ligelizumabIBA 09/2023 - 01/2023
2	Cyclin-Dependent Kinase 4IBA 01/2023 - 10/2020
2	Triglycerides (Triacylglycerol)IBA 01/2023 - 01/2020
2	LipidsIBA 09/2022 - 01/2020
2	Vasoconstrictor AgentsIBA 06/2022 - 01/2019
2	LuciferasesIBA 01/2022 - 10/2018
2	LSZ102IBA 01/2022 - 11/2021
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2021 - 01/2019
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2021 - 01/2020
2	ErbB Receptors (EGF Receptor)IBA 01/2021 - 09/2020
2	InterferonsIBA 07/2020 - 10/2015
2	Oxygen (Dioxygen)IBA 01/2020 - 11/2002
2	tiplaxtininIBA 01/2020 - 11/2016
2	NitrogenIBA 01/2020 - 07/2013
2	NF-kappa B (NF-kB)IBA 01/2020 - 01/2008
2	Plasminogen Activators (Plasminogen Activator)IBA 01/2020 - 11/2016
2	Interleukin-17 (Interleukin 17)IBA 08/2019 - 01/2019
2	Peptides (Polypeptides)IBA 01/2019 - 01/2013
2	LigandsIBA 01/2019 - 01/2016
2	AntibodiesIBA 01/2019 - 07/2008
2	ParaquatIBA 01/2017 - 08/2013
2	AntioxidantsIBA 12/2016 - 02/2009
2	CalciumIBA 09/2016 - 01/2015
2	naringinIBA 01/2016 - 11/2014
2	EnzymesIBA 07/2010 - 02/2009
2	1,25-dihydroxyvitamin DIBA 10/2006 - 01/2004
2	Cholecalciferol (Vitamin D3)FDA Link 07/2006 - 05/2002
2	CCAAT-Enhancer-Binding Protein-betaIBA 10/2005 - 01/2004
1	human ERBB2 proteinIBA 03/2024
1	Anastrozole (Arimidex)FDA LinkGeneric 03/2024

Therapy/Procedure

19	Therapeutics 03/2024 - 10/2005
4	Phacoemulsification 06/2020 - 01/2017
2	Drug Tapering 01/2024 - 12/2023
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2016 - 12/2014
2	Transplantation 10/2013 - 08/2013
2	Resuscitation 09/2009 - 11/2002